Kann, Hanna
59  results:
Search for persons X
?
2

Impact of ADAR-induced editing of minor viral RNA populatio..:

Ringlander, Johan ; Fingal, Joshua ; Kann, Hanna...
Proceedings of the National Academy of Sciences.  119 (2022)  6 - p. , 2022
 
?
 
?
6

Long‐term follow‐up of human papillomavirus type replacemen..:

Gray, Penelope ; Kann, Hanna ; Pimenoff, Ville N....
International Journal of Cancer.  147 (2020)  12 - p. 3511-3522 , 2020
 
?
7

Sustained Cross-reactive Antibody Responses After Human Pap..:

Kann, Hanna ; Lehtinen, Matti ; Eriksson, Tiina...
The Journal of Infectious Diseases.  223 (2020)  11 - p. 1992-2000 , 2020
 
?
8

Human papillomavirus types in cervical dysplasia among youn..:

Kann, Hanna ; Hortlund, Maria ; Eklund, Carina..
International Journal of Cancer.  146 (2020)  9 - p. 2539-2546 , 2020
 
?
9

Human Papillomavirus (HPV) seroprevalence, cervical HPV pre..:

Miyaji, Karina Takesaki ; Infante, Vanessa ; Picone, Camila de Melo...
https://researchonline.lshtm.ac.uk/id/eprint/4664750/1/Human%20Papillomavirus%20%28HPV%29%20seroprevalence,%20cervical%20HPV%20prevalence,%20genotype%20distribution%20and%20cytological%20lesions%20in%20solid%20o.pdf.  , 2022
 
?
 
?
11

Human papillomavirus seroprevalence in pregnant women follo..:

Gray, Penelope ; Kann, Hanna ; Pimenoff, Ville Nikolai...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pmed.1003588.  , 2021
 
?
13

Vaccine effectiveness against HPV infections:

Kann, Hanna
I. Artemchuk H, Triglav T, Oštrbenk A, Poljak M, Dillner J, Faust H. Seroprevalence of Antibodies to 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure. J Infect Dis. 2018; 218(3):398–405. ::doi::10.1093/infdis/jiy107 ::pmid::29529245 ::isi::000439174200008.  , 2020
 
?
15

A novel precision-serology assay for SARS-CoV-2 infection b..:

Samuel B. Lundin ; Hanna Kann ; Alma Fulurija...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1166924/full.  , 2023
 
1-15